Sanofi | SNY - Interest Income




Sanofi reported 133M in Interest Income for its fiscal quarter ending in September of 2024.

Interest Income Change Date
AbbVie USD 129M 91M Sep/2024
AstraZeneca 183M 83M Sep/2024
Canopy Growth CAD 2.42M 358K Sep/2024
Corcept Therapeutics USD 0.41 6M Sep/2024
Drreddys Laboratories INR 665M 79M Sep/2024
Eli Lilly USD 1.07 37.3M Sep/2024
Galapagos EUR 23.13M 582K Sep/2024
Genmab DKK 162M 130M Sep/2024
GlaxoSmithKline 32M 8M Sep/2024
Glaxosmithkline 32M 0 Sep/2024
Indivior 5M 1000K Sep/2024
J&J 292M 103M Sep/2024
Merck USD 1.24 69M Sep/2024
Pacira USD -3.11 4.75M Sep/2024
Pfizer USD 170M 54M Dec/2024
Roche Holding 2M 12M Dec/2020
Sanofi 133M 41M Sep/2024
Sanofi 133M 41M Sep/2024
Supernus Pharmaceuticals USD 0.69 3.73M Sep/2024
Zoetis 1.29 0.21 Dec/2024